Regeneron Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 19,539 | 0.0177% |
| State or Government | 125,460 | 0.114% |
| Individual Insiders | 4,496,508 | 4.08% |
| General Public | 12,026,268 | 10.9% |
| Institutions | 93,517,728 | 84.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 9,996,485 | R$48.5b | 4.83% | 0.63% | |||
| 8,838,285 | R$42.9b | 0.45% | 0.14% | |||
| 8,668,198 | R$42.1b | -0.56% | 0.43% | |||
| 8,629,707 | R$41.9b | -2.77% | 0.15% | |||
| 6,365,135 | R$30.9b | -2.69% | 0.77% | |||
| 4,901,251 | R$23.8b | 1.49% | 0.19% | |||
| 2,421,895 | R$11.8b | 0.51% | no data | |||
| 2,367,680 | R$11.5b | -0.22% | 0.66% | |||
| 2,354,217 | R$11.4b | 1.48% | 0.19% | |||
| 1,291,594 | R$6.3b | 1.11% | no data | |||
| 1,219,067 | R$5.9b | -1.12% | 1.62% | |||
| 1,210,735 | R$5.9b | 2.05% | 1.31% | |||
| 1,102,090 | R$5.4b | -26.9% | 0.16% | |||
| 1,061,803 | R$5.2b | 9.86% | 0.09% | |||
| 1,046,408 | R$5.1b | -1.95% | 0.16% | |||
| 985,540 | R$4.8b | 20.2% | 0.19% | |||
| 931,328 | R$4.5b | 1.59% | 0.49% | |||
| 919,309 | R$4.5b | 33.4% | 0.19% | |||
| 878,756 | R$4.3b | -6.64% | 0.16% | |||
| 801,318 | R$3.9b | 0.19% | 0.11% | |||
| 744,217 | R$3.6b | 7.51% | 0.23% | |||
| 718,052 | R$3.5b | -67.6% | 0.06% | |||
| 648,689 | R$3.2b | 8.91% | 0.19% | |||
| 629,690 | R$3.1b | 33.9% | 0.08% | |||
| 620,616 | R$3.0b | 0% | 0.11% |